NO307656B1 - Oligoribonukleotider med terminale 3'-3'-hhv. 5'-5'- sammenføyninger, anvendelse herav til fremstilling av et farmasøytisk preparat og legemiddel inneholdende disse nukleotider - Google Patents

Oligoribonukleotider med terminale 3'-3'-hhv. 5'-5'- sammenføyninger, anvendelse herav til fremstilling av et farmasøytisk preparat og legemiddel inneholdende disse nukleotider

Info

Publication number
NO307656B1
NO307656B1 NO933397A NO933397A NO307656B1 NO 307656 B1 NO307656 B1 NO 307656B1 NO 933397 A NO933397 A NO 933397A NO 933397 A NO933397 A NO 933397A NO 307656 B1 NO307656 B1 NO 307656B1
Authority
NO
Norway
Prior art keywords
terminal
oligoribonucleotides
junctions
nucleotides
manufacture
Prior art date
Application number
NO933397A
Other languages
English (en)
Norwegian (no)
Other versions
NO933397D0 (no
NO933397L (no
Inventor
Heinz Hartmut Seliger
Flavio Ramalho Ortigao
Hannelore Roesch
Rudi Roesch
Bernd Krist
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6468696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO307656(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO933397D0 publication Critical patent/NO933397D0/no
Publication of NO933397L publication Critical patent/NO933397L/no
Publication of NO307656B1 publication Critical patent/NO307656B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Shaping Of Tube Ends By Bending Or Straightening (AREA)
NO933397A 1992-09-24 1993-09-23 Oligoribonukleotider med terminale 3'-3'-hhv. 5'-5'- sammenføyninger, anvendelse herav til fremstilling av et farmasøytisk preparat og legemiddel inneholdende disse nukleotider NO307656B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4231949 1992-09-24

Publications (3)

Publication Number Publication Date
NO933397D0 NO933397D0 (no) 1993-09-23
NO933397L NO933397L (no) 1994-03-25
NO307656B1 true NO307656B1 (no) 2000-05-08

Family

ID=6468696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933397A NO307656B1 (no) 1992-09-24 1993-09-23 Oligoribonukleotider med terminale 3'-3'-hhv. 5'-5'- sammenføyninger, anvendelse herav til fremstilling av et farmasøytisk preparat og legemiddel inneholdende disse nukleotider

Country Status (14)

Country Link
US (1) US6420546B1 (da)
EP (1) EP0593901B2 (da)
JP (1) JP3653102B2 (da)
AT (1) ATE151773T1 (da)
AU (1) AU665113B2 (da)
CA (1) CA2106819C (da)
DE (1) DE59306170D1 (da)
DK (1) DK0593901T3 (da)
ES (1) ES2103408T3 (da)
FI (1) FI115400B (da)
GR (1) GR3023858T3 (da)
HU (1) HU219638B (da)
NO (1) NO307656B1 (da)
NZ (1) NZ248739A (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646042A (en) * 1992-08-26 1997-07-08 Ribozyme Pharmaceuticals, Inc. C-myb targeted ribozymes
US5998203A (en) * 1996-04-16 1999-12-07 Ribozyme Pharmaceuticals, Inc. Enzymatic nucleic acids containing 5'-and/or 3'-cap structures
ES2221942T3 (es) * 1996-05-24 2005-01-16 Aventis Pharma Deutschland Gmbh Reactivo y metodo para inhibir la expresion de n-ras.
US7572582B2 (en) 1997-09-12 2009-08-11 Exiqon A/S Oligonucleotide analogues
EP1071753A2 (en) * 1998-04-20 2001-01-31 Ribozyme Pharmaceuticals, Inc. Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
DE19935303A1 (de) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Oligonukleotide zur Inhibierung der Expression von humanem eg5
US7312325B2 (en) 2000-09-26 2007-12-25 Duke University RNA aptamers and methods for identifying the same
DK2070939T3 (da) 2001-05-25 2014-06-23 Univ Duke Modulatorer af farmakologiske midler
KR101147147B1 (ko) 2004-04-01 2012-05-25 머크 샤프 앤드 돔 코포레이션 Ｒｎａ 간섭의 오프 타겟 효과 감소를 위한 변형된폴리뉴클레오타이드
EP2460811A1 (en) 2004-04-22 2012-06-06 Regado Biosciences, Inc. Improved modulators of coagulation factors
US7923207B2 (en) 2004-11-22 2011-04-12 Dharmacon, Inc. Apparatus and system having dry gene silencing pools
US7935811B2 (en) 2004-11-22 2011-05-03 Dharmacon, Inc. Apparatus and system having dry gene silencing compositions
US20060166234A1 (en) 2004-11-22 2006-07-27 Barbara Robertson Apparatus and system having dry control gene silencing compositions
EP1820804A1 (en) * 2006-02-20 2007-08-22 Humboldt-Universität zu Berlin Lipidated oligonucleotides
AU2007299705B2 (en) 2006-09-22 2012-09-06 Dharmacon, Inc. Duplex oligonucleotide complexes and methods for gene silencing by RNA interference
US7845686B2 (en) * 2007-12-17 2010-12-07 S & B Technical Products, Inc. Restrained pipe joining system for plastic pipe
US8188060B2 (en) 2008-02-11 2012-05-29 Dharmacon, Inc. Duplex oligonucleotides with enhanced functionality in gene regulation
EP2781523A1 (en) 2013-03-18 2014-09-24 Miltenyi Biotec GmbH Lipophilic oligonucleotide analogs
CA3033867A1 (en) 2016-08-17 2018-02-22 Solstice Biologics, Ltd. Polynucleotide constructs
US11597744B2 (en) 2017-06-30 2023-03-07 Sirius Therapeutics, Inc. Chiral phosphoramidite auxiliaries and methods of their use
US11104941B2 (en) * 2018-09-28 2021-08-31 Bioo Scientific Corporation 5′ adapter comprising an internal 5′-5′ linkage
CN118373865B (zh) * 2024-06-25 2024-11-08 苏州诺维康生物科技有限公司 一种4-乙酰氨基-1-(2-脱氧-2-氟-beta-D-阿拉伯呋喃基)-2(1H)-嘧啶酮的新合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3916871A1 (de) 1989-05-24 1990-11-29 Boehringer Mannheim Gmbh Modifiziertes phosphoramidit-verfahren zur herstellung von modifizierten nukleinsaeuren
US5399676A (en) * 1989-10-23 1995-03-21 Gilead Sciences Oligonucleotides with inverted polarity
DE59108644D1 (de) * 1990-07-02 1997-05-07 Hoechst Ag Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-Internucleotidverknüpfungen
US5672697A (en) * 1991-02-08 1997-09-30 Gilead Sciences, Inc. Nucleoside 5'-methylene phosphonates
US5646261A (en) * 1992-01-22 1997-07-08 Hoechst Aktiengesellschaft 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use
KR930016437A (ko) * 1992-01-22 1993-08-26 귀틀라인, 슈미트 올리고뉴클레오티드 유사체, 이의 제조방법 및 용도

Also Published As

Publication number Publication date
NZ248739A (en) 1995-08-28
DE59306170D1 (de) 1997-05-22
NO933397D0 (no) 1993-09-23
ES2103408T3 (es) 1997-09-16
GR3023858T3 (en) 1997-09-30
EP0593901A2 (de) 1994-04-27
EP0593901B1 (de) 1997-04-16
DK0593901T3 (da) 1997-10-27
FI934154A7 (fi) 1994-03-25
EP0593901A3 (en) 1994-09-28
CA2106819A1 (en) 1994-03-25
JP3653102B2 (ja) 2005-05-25
JPH06189753A (ja) 1994-07-12
NO933397L (no) 1994-03-25
US6420546B1 (en) 2002-07-16
HU219638B (hu) 2001-06-28
ATE151773T1 (de) 1997-05-15
FI115400B (fi) 2005-04-29
EP0593901B2 (de) 2008-04-09
HUT66458A (en) 1994-11-28
AU4755193A (en) 1994-03-31
HU9302697D0 (en) 1993-12-28
CA2106819C (en) 2007-04-17
FI934154A0 (fi) 1993-09-22
AU665113B2 (en) 1995-12-14

Similar Documents

Publication Publication Date Title
NO307656B1 (no) Oligoribonukleotider med terminale 3'-3'-hhv. 5'-5'- sammenføyninger, anvendelse herav til fremstilling av et farmasøytisk preparat og legemiddel inneholdende disse nukleotider
ATE151076T1 (de) Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-internucleotidverknüpfungen
ATE419275T1 (de) Antikörper gegen vla-4
DE69713335D1 (de) Polymere zur abgabe von stickstoffoxide in vivo
DE69233117D1 (de) In sich geschlossende "sens-" und "antisense"-oligonukleotide und deren verwendungen
HUP0100786A3 (en) Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
DE69203104D1 (de) Herstellung von zellularen Elastomeren und chemische Zusammensetzungen zu deren Herstellung.
WO2000069901A3 (en) Proteins with insulin-like activity useful in the treatment of diabetes
MX22991A (es) Agente edulcorante derivado del acido l-aspartico o l-glutamico y el procedimiento para su preparacion.
DE69400342D1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluor-2-Chlorethan und Pentafluorethan
DE3683249D1 (de) 2-aminosulfonyl-6-nitrobenzoesaeureester oder amide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69524971D1 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
ITMI921235A0 (it) Oligonucleotidi antisenso ad attivita' antitumorale, composizioni farmaceutiche li comprendono e loro impieghi
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
IT9021300A0 (it) Composti aromatici contenenti gruppi solfo, loro preparazione e loro impiego
ATE69949T1 (de) Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3876114D1 (de) Benzodioxol-derivate, diese enthaltende zusammensetzungen und deren verwendung zur herstellung von medikamenten.
ZA906748B (en) Cyclic pyridine-2,4 and-2,5-dicarboxylic acid diamides,processes for their preparation and their use
DE69326050D1 (de) Verfahren zur Herstellung von 0,0'-Diacylweinsäureanhydrid und Verfahren zur Herstellung von 0,0'-Diacylweinsäure
DE69718168D1 (de) Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv
PH27586A (en) Low molecular weight derivatives of proukokinase pharmaceutical composition containing the same and method of use thereof
DE59305709D1 (de) Verfahren zur Herstellung von 1,4-Diaminoanthrachinon-2,3-disulfonsäure und 1,4-Diaminoanthrachinon-2,3-dinitril
RU93054766A (ru) Олигорибонуклеотиды и их рибозимные аналоги с концевыми 3'-3'-соответственно, 5'-5'-связями
DE69226336D1 (de) Formmasse, enthaltend feuerfeste Fasern, verwendbar in der Herstellung ablativer Teile, Verfahren zu ihrer Herstellung und ihre Anwendungen
DE69729780D1 (de) Protein mit Ethylendiamine-N,N'-Dibarnsteinsäure: Ethylendiamin Lyase Aktivität und dafür kodierendes Gen